A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data

BACKGROUND: In Germany, CRT devices with defibrillator capability (CRT-D) have become the predominant treatment strategy for patients with heart failure and cardiac dyssynchrony. However, according to current guidelines, most patients would also be eligible for the less expensive CRT pacemaker (CRT-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadwiger, Moritz, Schumann, Laura, Eisemann, Nora, Dagres, Nikolaos, Hindricks, Gerhard, Haug, Janina, Wolf, Michael, Marschall, Ursula, Katalinic, Alexander, Frielitz, Fabian-Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438143/
https://www.ncbi.nlm.nih.gov/pubmed/36056371
http://dx.doi.org/10.1186/s12962-022-00384-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438143/
https://www.ncbi.nlm.nih.gov/pubmed/36056371
http://dx.doi.org/10.1186/s12962-022-00384-x

Ejemplares similares